Literature DB >> 7478608

Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo.

S K Muthuswamy1, W J Muller.   

Abstract

Overexpression and amplification of the erbB-2 (neu) is thought to play a major role in mammary cancer. Although studies suggest that Neu is directly involved in the genesis of mammary tumors, the molecular mechanism by which Neu induces tumors is not well understood. Recently, we have demonstrated that the activity of c-Src tyrosine kinase is elevated in Neu-induced mammary tumors and this elevated activity correlates with its capacity to physically associate with Neu. To explore whether other members of the c-Src family are activated in these mammary tumors, we measured the in vitro kinase activity of the c-Yes and Fyn kinases in protein extracts derived from mammary tumor tissue and morphological normal adjacent tissue. These analyses revealed that c-Yes kinase activity was elevated in Neu-induced tumors by comparison to the adjacent tissue. By contrast, no significant activation of the Fyn kinase was noted in these tumors. Activation of c-Yes tyrosine kinase correlated with the capacity of c-Yes to associate with Neu in vivo in lysates derived from primary tumor samples. Studies with Rat.2 fibroblasts overexpressing activated Neu revealed that c-Src requires the presence of tyrosine phosphorylated Neu for its ability to interact with Neu in vivo. Moreover, analyses using radiolabeled c-Yes SH2 fusion protein revealed that this interaction is likely occurring in a direct fashion. Although both c-Src and c-Yes kinase associate with Neu in vivo, a tyrosine phosphorylated protein of 89 kd (p89) was found associated with c-Src but not with c-Yes in cell lysates derived from mammary epithelial cells transformed by either Neu or PyV middle T antigen. Furthermore, this tyrosine phosphorylated protein was not detected in c-Src complexes derived from fibroblasts transformed by either Neu or PyV middle T. These observations suggest that p89 associates with c-Src only in mammary epithelial cells and not in fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7478608

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  Loss of Hsp90 association up-regulates Src-dependent ErbB2 activity.

Authors:  Wanping Xu; Xitong Yuan; Kristin Beebe; Zhexin Xiang; Len Neckers
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

2.  Activation and association of Stat3 with Src in v-Src-transformed cell lines.

Authors:  X Cao; A Tay; G R Guy; Y H Tan
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

3.  SRC-family kinases are activated in non-small cell lung cancer and promote the survival of epidermal growth factor receptor-dependent cell lines.

Authors:  Jie Zhang; Shailaja Kalyankrishna; Marie Wislez; Nishan Thilaganathan; Babita Saigal; Wei Wei; Long Ma; Ignacio I Wistuba; Faye M Johnson; Jonathan M Kurie
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

4.  Identification of N-terminal lobe motifs that determine the kinase activity of the catalytic domains and regulatory strategies of Src and Csk protein tyrosine kinases.

Authors:  Kezhen Huang; Yue-Hao Wang; Alex Brown; Gongqin Sun
Journal:  J Mol Biol       Date:  2009-03-06       Impact factor: 5.469

5.  Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer.

Authors:  D Dankort; B Maslikowski; N Warner; N Kanno; H Kim; Z Wang; M F Moran; R G Oshima; R D Cardiff; W J Muller
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

6.  Src, Fyn, and Yes are not required for neuromuscular synapse formation but are necessary for stabilization of agrin-induced clusters of acetylcholine receptors.

Authors:  C L Smith; P Mittaud; E D Prescott; C Fuhrer; S J Burden
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

Review 7.  The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis.

Authors:  M M Moasser
Journal:  Oncogene       Date:  2007-04-30       Impact factor: 9.867

8.  Is expression or activation of Src kinase associated with cancer-specific survival in ER-, PR- and HER2-negative breast cancer patients?

Authors:  Beatrix Elsberger; Bingchao A Tan; Thomas J Mitchell; Sylvia B F Brown; Elizabeth A Mallon; Sian M Tovey; Timothy G Cooke; Valerie G Brunton; Joanne Edwards
Journal:  Am J Pathol       Date:  2009-09-17       Impact factor: 4.307

9.  c-Src associates with ErbB2 through an interaction between catalytic domains and confers enhanced transforming potential.

Authors:  Richard Marcotte; Lixin Zhou; Harold Kim; Calvin D Roskelly; William J Muller
Journal:  Mol Cell Biol       Date:  2009-08-24       Impact factor: 4.272

10.  Phosphorylation of the SRC epithelial substrate Trask is tightly regulated in normal epithelia but widespread in many human epithelial cancers.

Authors:  Ching Hang Wong; Frederick L Baehner; Danislav S Spassov; Deepika Ahuja; Donghui Wang; Byron Hann; Jimmy Blair; Kevan Shokat; Alana L Welm; Mark M Moasser
Journal:  Clin Cancer Res       Date:  2009-03-24       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.